Quantcast
Last updated on April 20, 2014 at 8:23 EDT

Latest CorAssist Stories

2008-09-18 09:00:49

CorAssist, a developer of novel therapeutic devices for Diastolic Heart Failure (DHF), announced today its flagship product, the ImCardia(TM), significantly improved DHF parameters in a first-of-its-kind preclinical study and has shown preliminary safety in two humans after three months follow up. After working closely for four years with researchers at the Technion - Israel Institute of Technology in Haifa, Israel, CorAssist successfully adapted an acute diastolic dysfunction canine...